Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 6.89% vs 28.76% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 13.71% vs 121.40% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 7.31% vs 17.69% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -22.18% vs 146.45% in Mar 2025
Compare Profit and Loss Results of Jagsonpal Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
287.00
176.00
111.00
63.07%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
287.00
176.00
111.00
63.07%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-16.00
16.00
100.00%
Raw Materials Consumed
105.00
129.00
-24.00
-18.60%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
70.00
5.00
65.00
1,300.00%
Operating Expenses
0.00
3.00
-3.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
28.00
0.00
28.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
229.00
130.00
99.00
76.15%
Operating Profit (PBDIT) excl Other Income
58.00
46.00
12.00
26.09%
Other Income
11.00
0.00
11.00
0%
Operating Profit (PBDIT)
70.00
46.00
24.00
52.17%
Interest
1.00
4.00
-3.00
-75.00%
Profit before Depriciation and Tax
69.00
42.00
27.00
64.29%
Depreciation
9.00
1.00
8.00
800.00%
Profit Before Taxation & Exceptional Items
59.00
40.00
19.00
47.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
57.00
40.00
17.00
42.50%
Provision for Tax
14.00
12.00
2.00
16.67%
Profit After Tax
43.00
27.00
16.00
59.26%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
148.00
23.00
125.00
543.48%
Profit Available for appropriations
191.00
50.00
141.00
282.00%
Appropriations
191.00
50.00
141.00
282.00%
Equity Dividend (%)
200%
0%
200.00
Earnings Per Share
6.4
5.84
0.56
9.59%
Profit And Loss - Net Sales
Net Sales 287.23 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.89% vs 28.76% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.07 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.71% vs 121.40% in Mar 2025
Profit And Loss - Interest
Interest 1.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.31% vs 17.69% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 43.08 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -22.18% vs 146.45% in Mar 2025
Footer loading
